This is the primary difference from semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP)
Hynes clarifies: Human studies have not been done to see if semaglutide increases the chance for pregnancy-related problems such as preterm delivery or low birth weight. Furthermore, the lack of data extends beyond pregnancy
However, please note that our BOGO offer is valid for in-clinic treatments only
He has also served on the speakers bureau of Eli Lilly & Co., Medscape, Medical Learning Institute, Menarini/Berlin Chemie, Merck, Sharp & Dohme, NovoNordisk, and Sun Pharmaceuticals
(PubMed) Kumaran S, Panneerselvam KS, Shila S, Sivarajan K, Panneerselvam C